Our Team

Cancer Prevention Pharmaceuticals, Inc. was founded by Dr. Frank Meyskens and Dr. Gene Gerner, both of whom are highly respected cancer prevention researchers involved in some of the largest and most well-known oncology research institutions including the National Cancer Institute (NCI) and SWOG. CPP’s team has significant experience in drug development, regulatory and commercialization.

Michelle Boytim, PHD
Program Manager, Clinical Research
Christine Brannen
Director of Operations
Elizabeth Bruckheimer, PhD
VP of Drug Development and Regulatory Affairs
Ashok Chavan, PhD
VP of CMC, QA, and Supply Chain
Alfred M. Cohen, MD, FACS, FASCRS
Chief Medical Officer
Dan Donovan
Director and Chief Business Officer
Eugene W. Gerner, PhD
Director and Chief Scientific Officer
Jeffrey Jacob
Chairman and CEO
Richard L. Love
Director

Jon S. Saxe
Director
Patrick Shannon, PhD
Project Management and CMC